UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-07, Vol.28 (19), p.3138-3145

2010

Link zum Volltext

Verfügbarkeit prüfen

Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first‐line metastatic renal carcinoma (SUNRISES study)

BJU international, 2020-11, Vol.126 (5), p.559-567

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2020-08, Vol.38 (22), p.2530-2542

2020

Link zum Volltext

Verfügbarkeit prüfen

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

The New England journal of medicine, 2009-09, Vol.361 (10), p.958-967

2009

Link zum Volltext

Verfügbarkeit prüfen

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Cancer medicine (Malden, MA), 2021-09, Vol.10 (17), p.5878-5888

2021

Link zum Volltext

Verfügbarkeit prüfen

Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

Clinical & translational oncology, 2024-03, Vol.26 (7), p.1647-1663

2024

Link zum Volltext

Verfügbarkeit prüfen

Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib

Anti-cancer drugs, 2015-01, Vol.26 (1), p.112-116

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

Journal of thoracic oncology, 2019-12, Vol.14 (12), p.2120-2132

2019

Link zum Volltext

Verfügbarkeit prüfen

Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

Lung cancer (Amsterdam, Netherlands), 2024-03, Vol.189, p.107451-107451, Article 107451

2024

Link zum Volltext

Verfügbarkeit prüfen

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

The New England journal of medicine, 2020-01, Vol.382 (1), p.41-50

2020

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib in renal cell carcinoma

Critical reviews in oncology/hematology, 2011-11, Vol.80 (2), p.314-322

2011

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-01, Vol.378 (2), p.113-125

2018

Link zum Volltext

Verfügbarkeit prüfen

Sequential therapy in metastatic renal cell carcinoma: pre-clinical and clinical rationale for selecting a second- or subsequent-line therapy with a different mechanism of action

Cancer and metastasis reviews, 2012-09, Vol.31 (Suppl 1), p.11-17

2012

Link zum Volltext

Verfügbarkeit prüfen

Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry

Lung cancer (Amsterdam, Netherlands), 2024-04, Vol.190, p.107513-107513, Article 107513

2024

Link zum Volltext

Verfügbarkeit prüfen

Difficulties on the access to innovative targeted therapies for lung cancer in Spain

Clinical & translational oncology, 2024-03, Vol.26 (3), p.597-612

2024

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)

Translational lung cancer research, 2019-08, Vol.8 (4), p.461-475

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

Clinical & translational oncology, 2011-12, Vol.13 (12), p.869-877

2011

Link zum Volltext

Verfügbarkeit prüfen

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

Journal of translational medicine, 2010-12, Vol.8 (1), p.135-135, Article 135

2010

Link zum Volltext

Verfügbarkeit prüfen

Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma

Cancer and metastasis reviews, 2010-08, Vol.29 (Suppl 1), p.1-10

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(97)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(50)
Humans
(46)
Oncology
(43)
Female
(30)
Male
(30)
Middle Aged
(30)
Aged
(28)
Adult
(25)
Lung Neoplasms - Drug Therapy
(22)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Biological And Medical Sciences
(14)
Carcinoma, Non-Small-Cell Lung - Genetics
(14)
Lung Cancer
(14)
Lung Neoplasms - Genetics
(14)
Medical Sciences
(14)
Metastasis
(14)
Lung Neoplasms - Pathology
(13)
Chemotherapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non–Small-Cell Lung Cancer

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics

Randomised Phase II study comparing alternating cycles of sunitinib and everolimus vs standard sequential administration in first‐line metastatic renal carcinoma (SUNRISES study)

Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology

Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish Lung Cancer Group GECP

Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trial

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

Sorafenib in renal cell carcinoma

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Sequential therapy in metastatic renal cell carcinoma: pre-clinical and clinical rationale for selecting a second- or subsequent-line therapy with a different mechanism of action

Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry

Difficulties on the access to innovative targeted therapies for lung cancer in Spain

Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry

Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study)

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma

Suchergebnisse filtern